Impact of tramadol and morphine abuse on the activities of acetylcholine esterase, Na+/K+-ATPase and related parameters in cerebral cortices of male adult rats
Keywords:
Morphine, Tramadol, Acetylcholine esterase (AChE), Na / K -ATPaseAbstract
Objective: To determine the effect of the most commonly abused drugs (tramadol and morphine), on acetylcholine esterase (AChE), Na+/K+-ATPase activities and related parameters, Na+ and K+ as biomarkers of neurotoxicity.
Methods: Tramadol - as a weak µ opioid receptor agonist- and morphine - as opiate analgesic drugs, were chosen for the present study. Four series of experimental animals were conducted for either tramadol or morphine: control series; repeated single equal doses (therapeutic dose) series; cumulative increasing doses series and delay (withdrawal) series (96 hours withdrawal period after last administration), at time period intervals 7, 14 and 21 days. Acetylcholine esterase (AChE), Na+/K+-ATPase activities and related parameters, Na+ and K+ were measured in cerebral cortices of experimental rats.
Results: Acetylcholine esterase (AChE) activity in the brain cerebral cortex increased after the administration of therapeutic repeated doses of either tramadol (20 mg/kg b.w.) or morphine (4 mg/kg b.w.) in different groups. The daily intraperitoneal injection of cumulative increasing dose levels of either tramadol 20, 40 and 80 mg/kg or morphine 4, 8 and 12 mg/kg revealed a significant increase in the mean of acetylcholine esterase activities. The withdrawal groups of either tramadol or morphine showed significant decreases in their levels. Na+/K+ ATPase activity in the brain cerebral cortex of either repeated therapeutic doses of tramadol (20 mg/kg) or morphine repeated therapeutic doses (4 mg/kg) for 21 consecutive days at different intervals 7, 14 and 21 days, induced a significant decrease in the levels of Na+/K+-ATPase in all groups. Withdrawal groups showed a significant decrease in Na+/K+-ATPase level. Furthermore, the daily intraperitoneal injection of cumulative increasing dose levels of either tramadol (20, 40 and 80 mg/kg b.w.) or morphine (4, 8 and12 mg/kg b.w.) induced significant decreases in Na+/K+-ATPase levels in all studied groups. Regarding Na+ and K+, concentrations of either repeated therapeutic doses or cumulative increasing doses at different time intervals, showed different fluctuations in their levels.
Conclusion: The recorded data suggest that both drugs exert potent effects on AChE and Na+/K+-ATPase activities which could contribute to cerebral cortex malfunction including, memory deficits and the decline in cognitive function observed in chronic users.
References
Bloms-Funke P, Dremencov E, Cremers TI, Tzschentke TM. Tramadol increases extracellular levels of
serotonin and noradrenaline as measured by in vivo microdialysis in the ventral hippocampus of freely- moving rats. Neurosc Lett. 2011; 490(3): 191-5. doi: 10.1016/j.neulet.2010.12.049. PMID: 21195741.
Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004; 43(13): 879-923.
doi: 10.2165/00003088-200443130-00004. PMID: 15509185.
Minami K, Ogata J, Horishita T, Shiraishi M, Okamoto T, Sata T, et al. Intramascular tramadol increases
gastric pH during anesthesia. Can J Anesth. 2004; 51(6): 545-8. doi: 10.1007/BF03018395. PMID:
Randall C, Crane J. Tramadol deaths in Northern Ireland: a review of cases from 1996 to 2012. J Forensic
Leg Med. 2014; 23: 32-6. doi: 10.1016/j.jflm.2014.01.006. PMID: 24661703.
El-Hadidy MA, Helaly AM. Medical and Psychiatric Effects of Long-Term Dependence on High Dose of
tramadol. Subst Use Misuse. 2015; 50(5): 582-9. doi: 10.3109/10826084.2014.991406. PMID: 25544109.
Tjäderborn M, Jönsson AK, Sandström TZ, Ahlner J, Hägg S. Non-prescribed use of psychoactive
prescription drugs among drug-impaired drivers in Sweden. Drug Alcohol Depend. 2016; 161: 77-85. doi:
1016/j.drugalcdep.2016.01.031. PMID: 26875672.
Howard B, Gutstein, Huda Akil. Opioid Analgesics. In: Pharmacological Basis of Therapetuics. 10th ed.
Goodman & Gilman, Macmillan Comp. London, Canada, Toronto: 2001; 569-70.
Plumb DC. Plumb’s Veterinary Drug Handbook. 7th ed. Stockholm, USA: Pharma Vet Inc; 2011.
Milatovic D, Gupta RC, Aschner M. Anticholinesterase toxicity and oxidative stress. Scientific World
Journal. 2006; 6: 295-310. doi: 10.1100/tsw.2006.38. PMID: 16518518.
Vasić V, Jovanović D, Horvat A, Momić T, Nikeziće G. Effect of Cd2+ and Hg2+ on the activity of
Na+/K+-ATPase and Mg2+-ATPase adsorbed on polystyrene microtiter plates. Anal Biochem. 2002;
(2): 113-20. doi: 10.1006/abio.2001.5405. PMID: 11779101.
Modi DN, Merchant MA. In vitro effects of aspirin and salycilate on erythrocytes: size and Na+/K+
ATPase activity. Ind J Pharmacol. 2003; 35: 27-31.
Sepúlveda J, Oliva P, Contreras E. Neuochemical changes of the extracellular concentrations of glutamate
and aspartate in the nucleus accumbens of rats after chronic administration of morphine. Eur J Pharmacol.
; 483(2-3): 249-58. doi: 10.1016/j.ejphar.2003.10.037. PMID: 14729114.
Atici S, Cinel L, Cinel I, Doruk N, Aktekin M, Akca A, et al. Opioid neurotoxicity: comparison of
morphine and tramadol in an experimental rat model. Int J Neurosci. 2004; 114(8): 1001-11. doi:
1080/00207450490461314.
Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res. 2011;
(2): 555-63. doi: 10.1016/j.bbr.2010.11.058. PMID: 21145918.
Tan CC, Yu JT, Wang HF, Tan MS, Meng XF, Wang C, et al. Efficacy and safety of donepezil,
galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review
and meta-analysis. J Alzheimers Dis. 2014; 41(2): 615-31. doi: 10.3233/JAD-132690. PMID: 24662102.
Campos C, Rocha NB, Vieira RT, Rocha SA, Telles-Correia D, Paes F, et al. Treatment of cognitive
deficits in Alzheimer's disease: a psychopharmacological review. Psychiatr Danub. 2016; 28(1): 2-12.
PMID: 26938815.
Pohanka M. Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity. Int J Mol Sci.
; 15(6): 9809-25. doi: 10.3390/ijms15069809. PMID: 24893223, PMCID: PMC4100123.
Hosseini-Sharifabad A, Rabbani M, Sharifzadeh M, Bagheri N. Acute and chronic tramadol administration
impair spatial memory in rat. Res Pharm Sci. 2016; 11(1): 49-57. PMID: 27051432, PMCID:
PMC4794937.
Ueda H, Inoue M, Matsumoto T. Protein kinase C-mediated inhibition of mu-opioid receptor
internalization and its involvement in the development of acute tolerance to peripheral mu-agonist
analgesia. J Neurosci. 2001; 21(9): 2967-73. PMID: 11312280.
Freye E, Latasch L. [Development of opioid tolerance -- molecular mechanisms and clinical
consequences]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2003; 38(1): 14-26. doi: 10.1055/s- 2003-36558. PMID: 12522725.
Dang VC, Williams JT. Chronic morphine treatment reduces recovery from opioid desensitization. J
Neurosci. 2004; 24(35): 7699-706. doi: 10.1523/JNEUROSCI.2499-04.2004. PMID: 15342737, PMCID:
PMC3631536.
Balzan S, D´urso G, Ghione S, Martinelli A, Montali U. Selective inhibition of human erythrocyte Na+/K+
ATPase by cardiac glycoside and by mammalian digitalis like factor. Life Sci. 2000; 67(16): 1921-8. doi:
1016/S0024-3205(00)00779-7.
Lees GJ. Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to
central nervous system neuropathology. Brain Res Brain Res Rev. 1991; 16(3): 283-300. doi:
1016/0165-0173(91)90011-V. PMID: 1665097.
Brines ML, Dare AO, de Lanerolle NC. The cardiac glycoside ouabain potentiates excitotoxic injury of
adult neurons in rat hippocampus. Neurosci Lett. 1995; 191(3): 145-8. doi: 10.1016/0304-3940(95)11577-J.
PMID: 7644134.
de Souza Wyse AT, Streck EL, Worm P, Wajner A, Ritter F, Netto CA. Preconditioning prevents the
inhibition of Na+, K+-ATPase activity after brain ischemia. Neurochem Res. 2000; 25(7): 971-5. doi:
1023/A:1007504525301. PMID: 10959493.
Horvat A, Momić T, Petrović S, Nikezić G, Demajo M. Selective inhibition of brain Na, K-ATPase by
drugs. Physiol Res. 2006; 55(3): 325-38. PMID: 16083303.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
